Literature DB >> 13888006

[On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].

U C DUBACH, A BLUMBERG.   

Abstract

Entities:  

Keywords:  DOPA/therapy; MALIGNANT CARCINOID SYNDROME/therapy

Mesh：

Substances：

Year:  1961        PMID： 13888006     DOI： 10.1007/bf01482661

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  4 in total

1.  Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.

Authors:  A SJOERDSMA; J A OATES; P ZALTZMAN; S UDENFRIEND
Journal:  N Engl J Med       Date:  1960-09-22       Impact factor: 91.245

2.  Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.

Authors:  F J COLLINI
Journal:  N Engl J Med       Date:  1961-05-11       Impact factor: 91.245

3.  The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay.

Authors:  S UDENFRIEND; E TITUS; H WEISSBACH
Journal:  J Biol Chem       Date:  1955-10       Impact factor: 5.157

4.  Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.

Authors:  J A OATES; L GILLESPIE; S UDENFRIEND; A SJOERDSMA
Journal:  Science       Date:  1960-06-24       Impact factor: 47.728
  4 in total
  2 in total

1.  Carcinoid syndrome: alleviation of diarrhoea and flushing with "Deseril" and Ro 5-1025.

Authors:  U C DUBACH; O R GSELL
Journal:  Br Med J       Date:  1962-05-19

2.  Effect of methyldopa in carcinoid disease.

Authors:  G I NICHOLSON; R O IRVINE
Journal:  Br Med J       Date:  1962-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.